BioCorRx (BICX) Current Assets (2010 - 2026)
BioCorRx's Current Assets was $1.02 million in Q1 2026, up 80.3% from $565,796 a year earlier and up 25.3% from the prior quarter.
Analysis
BioCorRx (BICX) Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Current Assets at BioCorRx came in at $814,468, up 590.3% from FY2024.
- Current Assets shows a five-year compound annual growth rate of -3.5% (FY2020 to FY2025).
- In earlier years, Current Assets was $117,996 in FY2024 (-36.9%), $187,119 in FY2023 (-41.0%), $316,910 in FY2022 (+38.8%) and $228,326 in FY2021 (-76.6%).
- Quarterly Current Assets has moved between $117,996 (Q4 2024) and $1.46 million (Q3 2025) over five years.
- Compared with a year earlier, Current Assets has increased for five straight quarters, with growth averaging 176.4% over the last eight quarters.
- The best year-over-year quarter for Current Assets over five years was Q4 2025 (growth of 590.3%); the worst was Q4 2021 (a decline of 76.6%).
- Per Business Quant data, BICX's Current Assets in the three quarters before Q1 2026 was $814,468 (Q4 2025), $1.46 million (Q3 2025) and $527,483 (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 65.26 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 56.35 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 37.48 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 38.94 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 34.36 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 16.55 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 45.01 Bn |
| 10 | BioCorRx | 3.46 Mn | 2.80 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.02 Mn |
| Dec 31, 2025 | 814,468.00 |
| Sep 30, 2025 | 1.46 Mn |
| Jun 30, 2025 | 527,483.00 |
| Mar 31, 2025 | 565,796.00 |
| Dec 31, 2024 | 117,996.00 |
| Sep 30, 2024 | 353,097.00 |
| Jun 30, 2024 | 172,010.00 |
| Mar 31, 2024 | 151,593.00 |
| Dec 31, 2023 | 187,119.00 |
| Sep 30, 2023 | 245,787.00 |
| Jun 30, 2023 | 429,693.00 |
| Mar 31, 2023 | 344,426.00 |
| Dec 31, 2022 | 316,910.00 |
| Sep 30, 2022 | 333,036.00 |
| Jun 30, 2022 | 368,063.00 |
| Mar 31, 2022 | 587,496.00 |
| Dec 31, 2021 | 228,326.00 |
| Sep 30, 2021 | 971,628.00 |
| Jun 30, 2021 | 822,907.00 |
API Access
BioCorRx Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=BICX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "BICX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=BICX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();